Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD
Open Access
- 1 April 2011
- journal article
- research article
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. 4, 37-47
Abstract
Purpose: Results of randomized controlled trials may not predict effectiveness of inhaled corticosteroids (ICS) in real-world clinical practice, where inhaler technique and device characteristics can influence effectiveness. We compared asthma outcomes for ICS delivered via three different inhaler devices: pressurized metered-dose inhaler (pMDI), breath-actuated MDI (BAI), and dry powder inhaler (DPI). Patients and methods: This retrospective database study evaluated 1-year outcomes for primary care patients with asthma aged 5–60 years prescribed their first ICS (initiation population) by pMDI (n = 39,746), BAI (n = 9809), or DPI (n = 6792), or their first ICS dose increase (step-up population) by pMDI (n = 6245), BAI (n = 1388), or DPI (n = 1536). Co-primary outcome measures were composite proxy measures of asthma control (no hospital attendance for asthma, oral corticosteroids, or antibiotics for lower respiratory infection) and severe exacerbations (unscheduled hospital admission, emergency room attendance, or oral corticosteroids). Outcomes were adjusted for potential confounding factors identified during a baseline year. Results: In the initiation population, adjusted odds ratios (95% confidence intervals [CI]) for asthma control, as compared with pMDIs, were significantly better for BAIs (1.08 [1.02–1.14]) and DPIs (1.13 [1.06–1.21]), while adjusted exacerbation rate ratios (95% CI) were 1.00 (0.93–1.08) and 0.88 (0.81–0.95), respectively. In the step-up population, adjusted odds of asthma control were 1.21 (1.05–1.39) for BAIs and 1.13 (0.99–1.29) for DPIs; adjusted exacerbation rate ratios were 0.83 (0.71–0.98) for BAIs and 0.85 (0.74–0.98) for DPIs, compared with pMDIs. Conclusion: Inhaler device selection may have a bearing on clinical outcomes. Differences in real-world effectiveness among these devices require closer evaluation in well-designed prospective trials.Keywords
This publication has 29 references indexed in Scilit:
- The ADMIT series - Issues in Inhalation Therapy. 6) Training tools for inhalation devicesPrimary Care Respiratory Journal, 2010
- Choosing inhaler devices for people with asthma: Current knowledge and outstanding research needsRespiratory Medicine, 2010
- Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational studyClinicoEconomics and Outcomes Research, 2010
- Inappropriate Use of Antibiotics for Acute Asthma in United States Emergency DepartmentsAcademic Emergency Medicine, 2008
- External validity of randomised controlled trials: “To whom do the results of this trial apply?”The Lancet, 2005
- Validity of the General Practice Research DatabasePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2003
- Improvement of asthma control with a breath-actuated pressurised metred dose inhaler (BAI): a prescribing claims study of 5556 patients using a traditional pressurised metred dose inhaler (MDI) or a breath-actuated deviceRespiratory Medicine, 2003
- Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literatureHealth Technology Assessment, 2001
- Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devicesRespiratory Medicine, 2000
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987